Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
High-yield synthesis method for palladium catalyst. Reduces cost and improves supply chain reliability for pharmaceutical intermediates and fine chemical manufacturing processes.
Novel chiral spirocyclic diphosphine ligand synthesis via patent CN1562926A. High enantioselectivity (98% ee) for asymmetric hydrogenation. Cost-effective supply chain solutions.
Patent CN108997144B details a mild, one-pot ferriporphyrin catalyzed trifluoroethylation method offering high yields and cost reduction in API manufacturing without noble metals.
Patent CN104311427B reveals novel energetic catalyst boosting propellant burn rate significantly while reducing pressure index for aerospace applications.
Patent CN105327703A details a recyclable gold nanocatalyst for quinazoline synthesis. This method eliminates hazardous oxidants, offering safer supply chains and cost-effective manufacturing for pharmaceutical intermediates.
Novel chiral N-heterocyclic carbene catalyst improves yield and dr value in asymmetric reactions, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN101289378A details a solvent-free chalcone synthesis using recyclable ionic liquids, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel catalytic method for halogenated biphenyl intermediates. High yield, reduced cost, scalable production for pharmaceutical applications ensuring supply chain reliability.
Advanced solid chiral catalyst process for florfenicol intermediates. Enhances yield, reduces environmental impact, and ensures supply chain reliability for veterinary drug manufacturers.
Patent CN112250597A reveals green synthesis for copper extractants. Achieve high purity and reduced waste with scalable manufacturing solutions.
Patent CN101580488B details TiCl4-catalyzed ligand synthesis yielding >80%. Enables high-selectivity linear alpha-olefin production with reduced costs.
Patent CN117362359A reveals record-breaking asymmetric hydrogenation technology. Achieve superior purity and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN110922427A reveals TMSOTf-catalyzed route for sterically hindered phosphonites. Green, solvent-free process offers cost reduction in pharma intermediate manufacturing.
Patent CN105753703B enables eco-friendly asymmetric hydroxylation using molecular oxygen. Delivers high purity intermediates with reduced environmental impact for global supply chains.
Patent CN104892540B reveals ionic liquid catalysis for naphthooxazinone derivatives offering green synthesis and supply chain advantages for reliable pharmaceutical intermediates supplier.
Novel strained-ring phosphine catalysts from patent CN108250239B enable efficient intramolecular Wittig reactions with high yields and simplified purification for API synthesis.
Novel barbituric acid-based carbon bond catalysts offering superior solubility and efficiency for pharmaceutical intermediate manufacturing.
Patent CN104151215B reveals high-purity acid catalysts enabling significant cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Patent CN108503659A reveals efficient lithium catalyst for ketone hydroboration. Reduces cost and time for pharmaceutical intermediate manufacturing significantly.
Novel KRED enzyme process for ticagrelor intermediate. High selectivity, mild conditions, cost-effective supply chain solution for pharma manufacturing.